Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Sells Two More Bioinformatics Platforms to Monsanto

Premium

WOBURN, Mass.--Israeli bioinformatics company Compugen, whose worldwide sales office is based here, has installed two additional high-throughput sequence analysis and bioinformatics platforms for Monsanto. Two BioXL/P-12 accelerators and associated GenCore and GenWeb software components will allow Monsanto to "add similarity annotation to genetic sequence data in an accurate and facile manner," according to Harry Harlow, Monsanto's director of bioinformatics.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.